Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy

    loading  Checking for direct PDF access through Ovid



Subcutaneous immunoglobulin appears to be an effective treatment alternative to intravenous immunoglobulin for patients with chronic inflammatory demyelinating polyneuropathy.


Markvadsen LH, et al, for The Danish CIDP and MMN Study Group. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2013;20:836-842.

Related Topics

    loading  Loading Related Articles